Neuroscience
Serotonin
100%
Selective Serotonin Reuptake Inhibitor
95%
Panic Disorder
81%
Major Depressive Disorder
77%
Obsessive-Compulsive Disorder
74%
Antidepressant
72%
Behavior (Neuroscience)
69%
Citalopram
60%
Dementia Praecox
59%
Serotonergic
46%
Anxiety Disorder
43%
Positron Emission Tomography
42%
Amygdala
41%
Female Rats
40%
Positron Emission Tomography
38%
Dissociative Identity Disorder
38%
Ketamine
38%
ABC Transporter Subfamily B
36%
Blood Brain Barrier
35%
Functional Magnetic Resonance Imaging
34%
5-HT1A Receptor
34%
Tryptophan
34%
Neurogenesis
33%
Prefrontal Cortex
31%
Hippocampus
31%
Cognitive Function
28%
C-Fos
26%
Meta-Chlorophenylpiperazine
25%
Cognitive Behavioral Therapy
25%
Cortisol
25%
Dissociative
24%
Microdialysis
24%
Neuronal Activity
24%
Receptor Antagonist
24%
Mood Disorder
23%
Metabolic Pathway
23%
Face
22%
Tumor Necrosis Factor Receptor
22%
Agomelatine
22%
Seasonal Affective Disorder
22%
Depression
22%
Hypothalamic-Pituitary-Adrenal Axis
21%
Receptor Agonists
21%
Cell Proliferation
21%
Social Anxiety Disorder
20%
Agonist
20%
Autoreceptor
20%
Hypothalamus
20%
In Vivo
20%
Agoraphobia
20%
Pharmacology, Toxicology and Pharmaceutical Science
Serotonin
79%
Selective Serotonin Reuptake Inhibitor
59%
Antidepressant
54%
Receptor
41%
Citalopram
36%
Symptom
32%
Tryptophan
31%
Agomelatine
30%
Obsessive Compulsive Disorder
28%
Hydrocortisone
28%
Major Depression
25%
Anxiety Disorder
24%
Ketamine
22%
Autoreceptor
20%
Placebo
19%
Tracer
19%
Social Phobia
19%
Panic
19%
Disease
18%
Receptor Agonist
18%
Clomipramine
17%
Pharmacotherapy
16%
Negative Syndrome
16%
Psychopharmacology
16%
Carcinoid Syndrome
15%
Glucocorticoid
15%
Depression
14%
Microdialysis
13%
Generalized Anxiety Disorder
13%
Receptor Antagonist
12%
Comorbidity
12%
Normal Human
11%
Mood Disorder
11%
Sumatriptan
10%
Corticosterone
10%
Carcinoid
10%
Placebo-Controlled Study
10%
Serotonin Agonist
10%
Meta-Chlorophenylpiperazine
10%
Doublecortin
10%
Serotonin 1B Antagonist
10%
Desensitization
10%
Typical Antipsychotic
9%
Noradrenalin
9%
Broxuridine
9%
Benzodiazepine
8%
Long Term Exposure
8%
Prevalence
8%
Interferon
7%
Tumor Necrosis Factor Receptor
7%
Keyphrases
Panic Disorder
22%
Obsessive-compulsive Disorder
15%
Citalopram
15%
Catechol-O-methyltransferase
15%
Cognitive Behavioral Therapy
15%
M100907
12%
5-hydroxytryptamine
10%
Tryptophan Depletion
9%
Acute Effects
9%
5-HT2A Receptor
8%
Patient Risk
8%
Control Subjects
8%
Psychiatric Disorders
8%
Selective Serotonin Reuptake Inhibitors
8%
Pharmacotherapy
8%
Neuroimaging Studies
7%
Amygdala
7%
Healthy Volunteers
7%
Pain Grading
7%
Somatosensory Abnormalities
7%
Somatosensory Profile
7%
Within-group
7%
Risk-taking
7%
Regional Cerebral Blood Flow (rCBF)
7%
Polymorphism
7%
Non-response
7%
Serum Serotonin
7%
Platelets
7%
Neuropsychopharmacology
7%
Group Differences
7%
Serotonin Synthesis
7%
External Feedback
7%
Diagnosis-related Groups
7%
Autoreceptor
7%
Desensitization
7%
Tianeptine
7%
Support Problem
7%
Mood Regulation
7%
Cervical Spine Involvement
7%
Lithium Concentration
7%
Turbo Spin Echo
7%
Inflammatory System
7%
Alpha Asymmetry
7%
Receptor 1
7%
5-hydroxytryptamine 1A Receptor
7%
Patient-reported Adverse Drug Reactions
7%
LY379268
7%
Metabotropic Glutamate Receptor 2 (mGluR2)
7%
Behavioral Correlates
7%
Polymorphic Variation
7%